Genomma Lab Internacional SAB de CV (GNMLF)
1.040
-0.02
(-1.90%)
USD |
OTCM |
Jan 16, 16:00
Genomma Lab Internacional EPS Diluted (Quarterly): 0.0239 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Corporativo Fragua SAB de CV | 0.00 |
| CEL-SCI Corp. | -0.7611 |
| AIM ImmunoTech, Inc. | -1.567 |
| IGC Pharma, Inc. | -0.0201 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 23.30M |
| Revenue (Quarterly) | 238.42M |
| Total Expenses (Quarterly) | 215.12M |
| Enterprise Value | 1.293B |
| Gross Profit Margin (Quarterly) | 63.86% |
| Profit Margin (Quarterly) | 9.77% |
| Earnings Yield | 8.81% |
| Operating Earnings Yield | 19.33% |
| Normalized Earnings Yield | 8.808 |